Prophylactic administration of haloperidol plus midazolam reduces postoperative nausea and vomiting better than using each drug alone in patients undergoing middle ear surgery

ABSTRACT

The efficacy of using midazolam or haloperidol for prevention of postoperative nausea and vomiting [PONV] has been investigated before. The main object of the present study was to evaluate the anti-emetic effects of combining administration of intravenous haloperidol with intravenous midazolam on PONV in patients underwent middle ear surgery in comparison with using each drug alone. Study design was randomized, double-blind, placebo-controlled. 80 patients, aged 18-60 years, scheduled for middle ear surgery in Kashani Hospital Medical Center under general anesthesia were enrolled in this randomized, double-blind, placebo-controlled study. Patients were divided into 4 groups of 20 each and received haloperidol 2 mg i.v. [Group H]; midazolam 2 mg i.v. [Group M]; haloperidol 2 mg plus midazolam 2 mg i.v. [Group HM]; saline i.v. [Group C]. The incidences of PONV and complete response were evaluated at 0-2 hours after arrival to the PACU and 2-24 hours after arrival to the ward in 4 groups. Patients in group HM had significantly lower incidence of PONV compared with groups H, M, and C throughout 0-24 h [P<00.5]. The HM group had the lowest incidence of PONV [0-2, 2-24, and 0-24 h] and the highest incidence of complete response. Postoperative anti-emetic requirement was significantly less in group HM compared with group M or H [P<0.05]. Combine administration of haloperidol 2 mg plus midazolam 2 mg significantly reduced PONV better than using each drug alone in patients underwent middle ear surgery under general anesthesia